Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,197
archived clinical trials in
Atrial Fibrillation

Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation
Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinical Foundation
mi
from
Cleveland, OH
Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation
Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinical Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Associates
mi
from
Birmingham, AL
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Associates
mi
from
Birmingham, AL
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Alabama Internal Medicine, PC
mi
from
Birmingham, AL
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Alabama Internal Medicine, PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Birmingham Heart Clinic
mi
from
Birmingham, AL
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Birmingham Heart Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
The Heart Center, PC
mi
from
Huntsville, AL
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
The Heart Center, PC
mi
from
Huntsville, AL
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Mobile Heart Specialists, PC
mi
from
Mobile, AL
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Mobile Heart Specialists, PC
mi
from
Mobile, AL
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Clara V. Massey, Md
mi
from
Mobile, AL
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Clara V. Massey, Md
mi
from
Mobile, AL
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Alaska Heart Institute
mi
from
Anchorage, AK
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Alaska Heart Institute
mi
from
Anchorage, AK
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Internal Medicine Physicians Associates
mi
from
Phoenix, AZ
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Internal Medicine Physicians Associates
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Southwest Heart
mi
from
Tucson, AZ
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Southwest Heart
mi
from
Tucson, AZ
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Pima Research Foundation
mi
from
Tucson, AZ
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Pima Research Foundation
mi
from
Tucson, AZ
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Dr. Rajesh Shroff
mi
from
Hot Springs, AR
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Dr. Rajesh Shroff
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Mary K. Richards, Md Pa
mi
from
Little Rock, AR
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Mary K. Richards, Md Pa
mi
from
Little Rock, AR
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Advanced Clinical Reserach Institute
mi
from
Anaheim, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Advanced Clinical Reserach Institute
mi
from
Anaheim, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Act/Cardiovascular Research Institute
mi
from
Beverly Hills, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Act/Cardiovascular Research Institute
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Capitol Interventional Cardiology
mi
from
Carmichael, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Capitol Interventional Cardiology
mi
from
Carmichael, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Escondido Cardiology Associates, Inc.
mi
from
Escondido, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Escondido Cardiology Associates, Inc.
mi
from
Escondido, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
William D. Bowden, D.O.
mi
from
Healdsburg, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
William D. Bowden, D.O.
mi
from
Healdsburg, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
La Mesa Cardiac Center, A Medical Group
mi
from
La Mesa, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
La Mesa Cardiac Center, A Medical Group
mi
from
La Mesa, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Coastal Cardiology
mi
from
Mission Viejo, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Coastal Cardiology
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Kenneth W. Carr Md
mi
from
Oceanside, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Kenneth W. Carr Md
mi
from
Oceanside, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Desert Med Grp Inc, Dba Desert Oasis Healthcare Med Group
mi
from
Palm Springs, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Desert Med Grp Inc, Dba Desert Oasis Healthcare Med Group
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Desert Cardiology Consultants Medical Group, Inc
mi
from
Rancho Mirage, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Desert Cardiology Consultants Medical Group, Inc
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Regional Cardiolody Associates
mi
from
Sacramento, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Regional Cardiolody Associates
mi
from
Sacramento, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Northern California Research
mi
from
Sacramento, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Northern California Research
mi
from
Sacramento, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Sacramento Heart and Vascular Medical Associates
mi
from
Sacramento, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Sacramento Heart and Vascular Medical Associates
mi
from
Sacramento, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Arrhythmia Consultants Of The Central Coast Medical Group
mi
from
Santa Barbara, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Arrhythmia Consultants Of The Central Coast Medical Group
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Northern California Medical Associates
mi
from
Santa Rosa, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Northern California Medical Associates
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Progressive Clinical Research
mi
from
Vista, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Progressive Clinical Research
mi
from
Vista, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Cardivasclular Consultants Medical Group
mi
from
Walnut Creek, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Cardivasclular Consultants Medical Group
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Shiva Heart Center Medical Group
mi
from
Wildomar, CA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Shiva Heart Center Medical Group
mi
from
Wildomar, CA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Electrophysiology Associates, Pc
mi
from
Colorado Springs, CO
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Electrophysiology Associates, Pc
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Aurora Denver Cardiology Associates
mi
from
Denver, CO
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Aurora Denver Cardiology Associates
mi
from
Denver, CO
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Denver VA Medical Center
mi
from
Denver, CO
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Denver VA Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
New West Physicians Clinical Research
mi
from
Golden, CO
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
New West Physicians Clinical Research
mi
from
Golden, CO
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
South Denver Cardiology Associates
mi
from
Littleton, CO
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
South Denver Cardiology Associates
mi
from
Littleton, CO
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Connecticut Clinical Research, LLC
mi
from
Bridgeport, CT
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Connecticut Clinical Research, LLC
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Bridgeport Hospital
mi
from
Bridgeport, CT
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Bridgeport Hospital
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Cardiology Associates Of New Haven,Pc
mi
from
Guilford, CT
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Cardiology Associates Of New Haven,Pc
mi
from
Guilford, CT
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
The William W. Backus Hospital
mi
from
Norwich, CT
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
The William W. Backus Hospital
mi
from
Norwich, CT
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Stamford Therapeutics Consortium
mi
from
Stamford, CT
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Stamford Therapeutics Consortium
mi
from
Stamford, CT
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Chase Medical Research, LLC
mi
from
Waterbury, CT
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Chase Medical Research, LLC
mi
from
Waterbury, CT
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Alfieri Cardiology
mi
from
Newark, DE
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Alfieri Cardiology
mi
from
Newark, DE
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
George Washington University Medical Faculty Associates
mi
from
Washington,
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
George Washington University Medical Faculty Associates
mi
from
Washington,
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Washington VA Medical Center
mi
from
Washington,
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Washington VA Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Medical Specialist Of The Palm Beach
mi
from
Atlantis, FL
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Medical Specialist Of The Palm Beach
mi
from
Atlantis, FL
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Miami International Cardiology Consultants
mi
from
Aventura, FL
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Miami International Cardiology Consultants
mi
from
Aventura, FL
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
David Charles Mishkel, Md, Pa
mi
from
Boca Raton, FL
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
David Charles Mishkel, Md, Pa
mi
from
Boca Raton, FL
Click here to add this to my saved trials